We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry
Mult. Scler. 2022 Nov 26;[EPub Ahead of Print], T Spelman, S Ozakbas, R Alroughani, M Terzi, S Hodgkinson, G Laureys, T Kalincik, A Van Der Walt, B Yamout, J Lechner-Scott, A Soysal, J Kuhle, JL Sanchez-Menoyo, Y Blanco Morgado, D Spitaleri, V van Pesch, D Horakova, R Ampapa, F Patti, R Macdonell, A Al-Asmi, O Gerlach, J Oh, A Altintas, N Tundia, SL Wong, H Butzkueven